A Day Up For Cortexyme, Inc.
Mon, Aug 09, 2021 at 05:30 PM
Cortexyme, Inc. (CRTX:NASDAQ) shot up at $98.91, representing a gain of 47.3%. The stock appeared on our News Catalysts scanner on Mon, Aug 09, 2021 at 09:42 AM in the 'INVESTOR UPDATE' category. From Fri, Jul 23, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cortexyme, Inc. (CRTX:NASDAQ)
Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic virulence factor proteases, called gingipains.
Top 10 Gainers:
- GNOG (GNOG:NASDAQ), 50.77%
- Cortexyme, Inc. (CRTX:NASDAQ), 47.32%
- Tarena International, Inc. (TEDU:NASDAQ), 40.3%
- China XD Plastics Company Limited (CXDC:NASDAQ), 35.48%
- Washington Prime Group Inc. (WPG:NYSE), 34.4%
- Select Interior Concepts, Inc. (SIC:NASDAQ), 29.79%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 27.62%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 22.82%
- BTCM (BTCM:NYSE), 21.66%
- CNTB (CNTB:NASDAQ), 20.46%